Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoon-Kyo An

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of Crohn'S & Colitis|April 29, 2020
Monitoring Inflammatory Bowel Disease in Pregnancy Using Gastrointestinal UltrasonographyEmma Flanagan, Emily K Wright, Jakob Begun, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|April 14, 2020
Gastrointestinal ultrasound in inflammatory bowel disease care: Patient perceptions and impact on disease-related knowledgeArvind Rajagopalan, Dharshan Sathananthan, Yoon-Kyo An, et al.
Therapeutic Advances in Gastroenterology|March 26, 2026
Examining attitudes to intestinal ultrasound in inflammatory bowel disease: a national survey of Australian gastroenterologistsLynna Chen, Leonie Ruddick-Collins, Yoon-Kyo An, et al.
Crohn'S & Colitis 360|May 5, 2025
The Durability of Anti-TNF Therapy for Crohn's Disease Is Higher in Anti-TNF Naïve Patients and Increases With Proactive Therapeutic Drug MonitoringRobert Gilmore, Richard Fernandes, Tamar Schildkraut, et al.
Journal of Gastroenterology and Hepatology|February 28, 2025
Comparing Long-Term Infliximab Persistence Following a Switch to a Biosimilar in Patients With Inflammatory Bowel Disease: No Cause for ConcernPaulina Suo, Ashish Srinivasan, Lena Thin, et al.
Journal of Gastroenterology and Hepatology|December 22, 2017
Predicting response after infliximab salvage in acute severe ulcerative colitisMatthew C Choy, Dean Seah, Alexandra Gorelik, et al.
Inflammatory Bowel Diseases|January 4, 2019
Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative ColitisMatthew C Choy, Dean Seah, David M Faleck, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2024
Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: A Randomized Controlled TrialAviv Pudipeddi, Sudarshan Paramsothy, Viraj Kariyawasam, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2024
Vedolizumab and Ustekinumab Levels in Pregnant Women With Inflammatory Bowel Disease and Infants Exposed In UteroRalley Prentice, Emma Flanagan, Emily K Wright, et al.
Intestinal Research|December 22, 2024
Upadacitinib induction is effective and safe in ulcerative colitis patients including those with prior exposure to tofacitinib: a multicenter real-world cohort studyRobert Gilmore, Richard Fernandes, Imogen Hartley, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Crohn'S & Colitis|April 29, 2020
Monitoring Inflammatory Bowel Disease in Pregnancy Using Gastrointestinal UltrasonographyEmma Flanagan, Emily K Wright, Jakob Begun, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|April 14, 2020
Gastrointestinal ultrasound in inflammatory bowel disease care: Patient perceptions and impact on disease-related knowledgeArvind Rajagopalan, Dharshan Sathananthan, Yoon-Kyo An, et al.
Therapeutic Advances in Gastroenterology|March 26, 2026
Examining attitudes to intestinal ultrasound in inflammatory bowel disease: a national survey of Australian gastroenterologistsLynna Chen, Leonie Ruddick-Collins, Yoon-Kyo An, et al.
Crohn'S & Colitis 360|May 5, 2025
The Durability of Anti-TNF Therapy for Crohn's Disease Is Higher in Anti-TNF Naïve Patients and Increases With Proactive Therapeutic Drug MonitoringRobert Gilmore, Richard Fernandes, Tamar Schildkraut, et al.
Journal of Gastroenterology and Hepatology|February 28, 2025
Comparing Long-Term Infliximab Persistence Following a Switch to a Biosimilar in Patients With Inflammatory Bowel Disease: No Cause for ConcernPaulina Suo, Ashish Srinivasan, Lena Thin, et al.
Journal of Gastroenterology and Hepatology|December 22, 2017
Predicting response after infliximab salvage in acute severe ulcerative colitisMatthew C Choy, Dean Seah, Alexandra Gorelik, et al.
Inflammatory Bowel Diseases|January 4, 2019
Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative ColitisMatthew C Choy, Dean Seah, David M Faleck, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2024
Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: A Randomized Controlled TrialAviv Pudipeddi, Sudarshan Paramsothy, Viraj Kariyawasam, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2024
Vedolizumab and Ustekinumab Levels in Pregnant Women With Inflammatory Bowel Disease and Infants Exposed In UteroRalley Prentice, Emma Flanagan, Emily K Wright, et al.
Intestinal Research|December 22, 2024
Upadacitinib induction is effective and safe in ulcerative colitis patients including those with prior exposure to tofacitinib: a multicenter real-world cohort studyRobert Gilmore, Richard Fernandes, Imogen Hartley, et al.
Pageof 3